PubMed COVID-19 Clinical Care
38971 - 38980 of 44782 results found
Friendship in the age of COVID-19
Description
No abstract
SARS-CoV-2 serological assay and viral testing: a report of professional football setting
Description
CONCLUSION: Our study revealed an inconsistency of results between the two tests; therefore, although application of serological assays alone seems insufficient in diagnosing COVID-19 disease, the findings are beneficial in the comprehension and the
Small molecules in the race of COVID-19 drug development
Description
COVID-19, caused by SARS-CoV-2, is spreading worldwide, regardless of different continents, increasing the death toll to almost five million, with more than 300 million reported cases. Researchers have been fighting the greatest threats to human
Life and Money? Life or Money? -Health Economic Assessment and Value Assessment for Oncology Medications
Description
Health economics seek to provide the information which can contribute to the rational decision making, towards the appropriate allocation of scarce healthcare resources. Through the COVID-19 pandemic, everyone has recognized that healthcare resource
Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19
Description
CONCLUSIONS: Most patients with COVID-19 admitted to the intensive care are not suitable for APP. Of those who are, many cannot tolerate more than two episodes. Improvements in SpO2/FiO2 secondary to APP are transient and most likely in the first
Review of COVID-19 vaccine subtypes, efficacy and geographical distributions
Description
As of 1 May 2021, there have been 152 661 445 Covid-19 cases with 3 202 256 deaths globally. This pandemic led to the race to discover a vaccine to achieve herd immunity and curtail the damaging effects of Covid-19. This study aims to discuss the
Fake COVID-19 vaccinations in Africa
Description
No abstract
Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report
Description
A 44-year-old female patient with multiple sclerosis (MS) treated with ocrelizumab was hospitalized with SARS-CoV-2 pneumonia three times over the course of five months, eventually expiring. Viral sequencing of samples from her first and last
Experiment aversion among clinicians and the public - an obstacle to evidence-based medicine and public health
Description
CONCLUSIONS: Advancing evidence-based medicine through pragmatic RCTs will require anticipating and addressing experiment aversion among both patients and healthcare professionals.